This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ilyas, M. Articles by Talbot, I. C. Search for Related Content PubMed PubMed Citation Articles by Ilyas, M. Articles by Talbot, I. C.

American Journal of Pathology, Vol 149, 1719-1726, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Bcl-2 expression in colorectal tumors: evidence of different pathways in sporadic and ulcerative-colitis-associated carcinomas

M Ilyas, IP Tomlinson, AM Hanby, T Yao, WF Bodmer and IC Talbot
Colorectal Cancer Unit, Imperial Cancer Research Fund, St. Mark's Hospital, Harrow, United Kingdom.

Colorectal cancers (CRCs) differ in their age at presentation, distribution, histological features, and prognosis. If tumor biology reflects genetic events, these tumors might be expected to show differences in their genetic pathways. In this study, we investigated the role of Bcl-2 in the development of three different tumor groups. Using markers at eight different microsatellite locl, we characterized one group of 34 left-sided sporadic CRCs as replication error negative (RER-) and another group of 18 left-sided sporadic CRCs as replication error positive (RER+). These tumors, together with a third group of 22 left-sided ulcerative-colitis-associated CRCs (UCACRCs), were then examined by immunohistochemistry for Bcl-2 overexpression. Of 34 of the RER- tumors, 21 (62%) and 10 of 18 (56%) of the RER+ tumors were positive for Bcl-2 overexpression. In contrast, only 5 of 22 (23%) of the UCACRCs showed similar overexpression. Our results show a significantly lower frequency of Bcl-2 overexpression in UCACRCs as compared with sporadic CRCs (P < 0.005) but no difference between sporadic left-sided RER+ and RER- CRCs. These data provide additional evidence that UCACRCs may develop along a pathway that is different from that of sporadic CRCs.

This article has been cited by other articles:

				J M D Wheeler, H C Kim, J A Efstathiou, M Ilyas, N J M. Mortensen, and W F Bodmer Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer Gut, March 1, 2001; 48(3): 367 - 371. [Abstract] [Full Text] [PDF]

				S. Walsh, M. Murphy, M. Silverman, R. Odze, D. Antonioli, H. Goldman, and M. Loda p27 Expression in Inflammatory Bowel Disease-Associated Neoplasia : Further Evidence of a Unique Molecular Pathogenesis Am. J. Pathol., November 1, 1999; 155(5): 1511 - 1518. [Abstract] [Full Text] [PDF]

				M Ilyas, X-P Hao, K Wilkinson, I P M Tomlinson, A M Abbasi, A Forbes, W F Bodmer, and I C Talbot Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer Gut, September 1, 1998; 43(3): 383 - 387. [Abstract] [Full Text] [PDF]